key considerations when integrating an end-to-end single-use mabs production facility
Published 1 year ago • 217 plays • Length 4:14Download video MP4
Download video MP3
Similar videos
-
49:15
continuous and intensified bioprocessing: a practical guide
-
46:21
webinar: integration strategies for commercial single-use biomanufacturing facilities
-
16:37
high titer mab production in single-use bioreactors
-
8:25
monoclonal antibody structure and function
-
2:17
ambr® crossflow: high throughput solution for parallel screening
-
7:11
monoclonal antibodies (ib biology)
-
3:57
monoclonal antibodies | health | biology | fuseschool
-
![sartorius trends & challenges adc biomanufacturing [en]](https://i.ytimg.com/vi/7ene6ucvmzQ/mqdefault.jpg)
2:32
sartorius trends & challenges adc biomanufacturing [en]
-
3:32
monoclonal antibodies and its production
-
3:24
what is cell line development? key steps for biopharmaceutical production
-
1:38
monoclonal antibody analysis update better separations of mab variants
-
![sartorius trends and challenges monoclonal antibodies manufacturing [en]](https://i.ytimg.com/vi/ijuv4CvhXuY/mqdefault.jpg)
1:42
sartorius trends and challenges monoclonal antibodies manufacturing [en]
-
58:18
mike kowalski and david apiyo - automated optimization of igg production in cho cells
-
53:28
process intensification with continuous disposable technology
-
5:54
monoclonal antibody production using hybridoma technology
-
1:41
what are monoclonal antibodies?
-
2:01
monoclonal antibodies generation against natural products | protocol preview
-
2:01
monoclonal antibodies generation from rare antigen-specific b cells | protocol preview
-
53:33
early process development options and speed to clinic webinar